Radhika R. Peddinti to Antigens, CD34
This is a "connection" page, showing publications Radhika R. Peddinti has written about Antigens, CD34.
Connection Strength
0.054
-
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease. N Engl J Med. 2023 Aug 31; 389(9):820-832.
Score: 0.054